Pharsight Monthly Summary
NOVEMBER, 2023
Recent happenings in patent protected drugs.
spacer_11
At a Glance
61
drug patents lapsed
Photos
128
new drug patents introduced
Reviews
spacer_11
Companies who recently launched drugs
 
 
ABBVIE
 
ALKERMES INC
 
AM REGENT
 
ANTARES PHARMA INC
 
ARCUTIS
 
ARDELYX INC
 
ASTELLAS
 
AVADEL CNS
 
AZURITY
 
BIOGEN INC
 
BRISTOL
 
CATALYST PHARMS
 
CUMBERLAND PHARMS
 
DECIPHERA PHARMS
 
ELI LILLY AND CO
 
EUGIA PHARMA SPECLTS
 
EVOKE PHARMA INC
 
EXELA PHARMA
 
GLAXO GRP LTD
 
GLAXOSMITHKLINE
 
HIKMA
 
INTRA-CELLULAR
 
IPSEN
 
KARYOPHARM THERAPS
 
MAYNE PHARMA
 
MITSUBISHI TANABE
 
NORTON WATERFORD
 
ORASIS PHARMS
 
PACIRA PHARMS INC
 
PFIZER
 
PHATHOM
 
SERVIER
 
SPRINGWORKS
 
TAKEDA PHARMS USA
 
UCB INC
 
UNITED THERAP
 
VANDA PHARMS INC
 
VIFOR PHARMA
 
VISIOX PHARMA
 
ZEALAND PHARMA
 
 
spacer_11
Drugs not protected by their main patents
Drug Company
ABILIFY OTSUKA
ABILIFY MYCITE KIT OTSUKA
ADASUVE ALEXZA PHARMS
ADDYI SPROUT PHARMS
ADLYXIN SANOFI-AVENTIS US
AGGRASTAT MEDICURE
ARNUITY ELLIPTA GLAXOSMITHKLINE
AXUMIN BLUE EARTH
CLEVIPREX CHIESI
COPAXONE TEVA PHARMS USA
DALIRESP ASTRAZENECA
DEXILANT TAKEDA PHARMS USA
DEXILANT SOLUTAB TAKEDA PHARMS USA
EMEND MSD MERCK CO
EPIVIR VIIV HLTHCARE
FERAHEME COVIS
FLONASE SENSIMIST ALLERGY RELIEF HALEON US HOLDINGS
GADAVIST BAYER HLTHCARE
GILENYA NOVARTIS
GLEEVEC NOVARTIS
IRESSA ASTRAZENECA
JADENU SPRINKLE NOVARTIS
JUXTAPID CHIESI
LEVEMIR FLEXTOUCH NOVO NORDISK INC
LIPTRUZET ORGANON
LUMASON BRACCO
LYRICA CR UPJOHN
MACRILEN NOVO
MYRBETRIQ GRANULES APGDI
NEXIUM 24HR ASTRAZENECA LP
NORDITROPIN FLEXPRO NOVO NORDISK INC
NOVOLOG FLEXTOUCH NOVO NORDISK INC
NOXAFIL MERCK SHARP DOHME
ORBACTIV MELINTA THERAP
REYATAZ BRISTOL MYERS SQUIBB
SAXENDA NOVO
SELZENTRY VIIV HLTHCARE
SOLIQUA 100/33 SANOFI-AVENTIS US
SOMAVERT PHARMACIA
SPIRIVA RESPIMAT BOEHRINGER INGELHEIM
SYNRIBO TEVA PHARMS INTL
TORISEL PF PRISM CV
TRUVADA GILEAD
VASCEPA AMARIN PHARMS
VELPHORO VIFOR FRESENIUS
VENLAFAXINE BESYLATE ALMATICA
VIIBRYD ABBVIE
VYVANSE TAKEDA PHARMS USA
XEPI FERRER INTERNACIONAL
XTORO FONSECA BIOSCIENCES
ZYVOX PFIZER
Drug patents lapsed
Drug Patent Patent expiry
ACTONEL 7192938*PED Nov, 2023
ACTONEL 7718634*PED Nov, 2023
AIRDUO DIGIHALER 7540282*PED Nov, 2023
AIRDUO RESPICLICK 7540282*PED Nov, 2023
AMRIX 7544372 Nov, 2023
AMRIX 7790199 Nov, 2023
AMRIX 7820203 Nov, 2023
AMRIX 7829121 Nov, 2023
AMRIX 8877245 Nov, 2023
AMRIX 9375410 Nov, 2023
AMRIX 9399025 Nov, 2023
ARMONAIR DIGIHALER 7540282*PED Nov, 2023
ARMONAIR RESPICLICK 7540282*PED Nov, 2023
DALVANCE 7115564 Nov, 2023
DALVANCE 7119061 Nov, 2023
DALVANCE 8143212 Nov, 2023
ENTRESTO 7468390 Nov, 2023
EXFORGE HCT 8475839*PED Nov, 2023
HYSINGLA ER 10130591 Nov, 2023
HYSINGLA ER 8309060 Nov, 2023
KYLEENA 7252839 Nov, 2023
LEQVIO 10266825 Nov, 2023
LEQVIO 11078485 Nov, 2023
LONHALA MAGNAIR KIT 8511581 Nov, 2023
MYRBETRIQ 7342117 Nov, 2023
MYRBETRIQ 7982049 Nov, 2023
MYRBETRIQ 8835474 Nov, 2023
MYRBETRIQ RE44872 Nov, 2023
MYRBETRIQ GRANULES 7342117 Nov, 2023
MYRBETRIQ GRANULES 7982049 Nov, 2023
NUCYNTA ER 8075872 Nov, 2023
NUCYNTA ER 8309060 Nov, 2023
NUCYNTA ER 8420056 Nov, 2023
NUVIGIL 7297346 Nov, 2023
ONPATTRO 9943538 Nov, 2023
ONPATTRO 9943539 Nov, 2023
OPANA ER 8075872 Nov, 2023
OPANA ER 8309060 Nov, 2023
OXAYDO 7510726 Nov, 2023
OXAYDO 7981439 Nov, 2023
OXAYDO 8409616 Nov, 2023
OXAYDO 8637540 Nov, 2023
OXYCONTIN 10130591 Nov, 2023
OXYCONTIN 10675278 Nov, 2023
OXYCONTIN 8309060 Nov, 2023
OZURDEX 6899717 Nov, 2023
PATADAY ONCE DAILY RELIEF 6995186 Nov, 2023
POMALYST 8673939*PED Nov, 2023
POMALYST 8735428*PED Nov, 2023
PROMACTA 7795293*PED Nov, 2023
PROMACTA KIT 7795293*PED Nov, 2023
PROVIGIL 7297346 Nov, 2023
RUBRACA 6495541 Nov, 2023
SKYLA 7252839 Nov, 2023
STIOLTO RESPIMAT 7491719 Nov, 2023
STIOLTO RESPIMAT 7786111 Nov, 2023
STIOLTO RESPIMAT 8044046 Nov, 2023
STRIVERDI RESPIMAT 7491719 Nov, 2023
STRIVERDI RESPIMAT 7786111 Nov, 2023
STRIVERDI RESPIMAT 8044046 Nov, 2023
XEPI 6335447 Nov, 2023
Newly introduced Drug Patents
Drug Patent Patent expiry
AGAMREE 10857161 May, 2029
AGAMREE 11382922 Jul, 2040
AGAMREE 11471471 Mar, 2040
AGAMREE 11690853 Mar, 2033
AGAMREE 8334279 May, 2029
ANORO ELLIPTA 7439393*PED Nov, 2025
ANORO ELLIPTA 8113199*PED Apr, 2028
ANORO ELLIPTA 8161968*PED Aug, 2028
ANORO ELLIPTA 8511304*PED Dec, 2027
ANORO ELLIPTA 8534281*PED Sep, 2030
ANORO ELLIPTA 8746242*PED Apr, 2031
ANORO ELLIPTA 9333310*PED Apr, 2028
BIJUVA 11793819 Nov, 2032
BREO ELLIPTA 11116721*PED Aug, 2029
BREO ELLIPTA 7439393*PED Nov, 2025
BREO ELLIPTA 8113199*PED Apr, 2028
BREO ELLIPTA 8161968*PED Aug, 2028
BREO ELLIPTA 8511304*PED Dec, 2027
BREO ELLIPTA 8534281*PED Sep, 2030
BREO ELLIPTA 8746242*PED Apr, 2031
BREO ELLIPTA 9333310*PED Apr, 2028
BYLVAY 11801226 Jun, 2039
BYLVAY 11802115 Jun, 2039
CALDOLOR 11806400 Mar, 2032
CAPLYTA 11806348 Aug, 2039
COMBOGESIC IV 11213498 Jan, 2036
COMBOGESIC IV 11389416 Jul, 2035
COMBOGESIC IV 11446266 Oct, 2031
CRESEMBA 10206879*PED Mar, 2028
CRESEMBA 10603280*PED Mar, 2028
CRESEMBA 6812238*PED May, 2026
CYCLOPHOSPHAMIDE 9662342 Jun, 2035
ELCYS 11826383 Jan, 2039
EXPAREL 11819575 Jan, 2041
FINTEPLA 11786487 Aug, 2037
FRUZAQLA 10519142 Sep, 2035
FRUZAQLA 11046674 Sep, 2035
FRUZAQLA 7829574 May, 2028
FRUZAQLA 8212033 May, 2028
GIMOTI 11813231 Dec, 2029
HETLIOZ 11786502 Oct, 2034
HETLIOZ LQ 11786502 Oct, 2034
LUMRYZ 11826335 Jul, 2037
LYBALVI 11793805 Aug, 2031
MULTRYS 11786548 Jul, 2041
NYMALIZE 11806338 Apr, 2038
OGSIVEO 10590087 Aug, 2039
OGSIVEO 10710966 Aug, 2039
OGSIVEO 10941118 Aug, 2039
OGSIVEO 11504354 Jul, 2042
OGSIVEO 11612588 Jul, 2042
OGSIVEO 11807611 Sep, 2042
OGSIVEO 11820748 Aug, 2039
OGSIVEO 7342118 Aug, 2025
OGSIVEO 7795447 Aug, 2025
OGSIVEO 7951958 Mar, 2025
OLUMIANT 11806555 Nov, 2031
OMLONTI 11793798 Jan, 2035
QINLOCK 11801237 Dec, 2040
QINLOCK 11813251 Aug, 2040
QLOSI 10639297 Aug, 2037
QLOSI 11129812 Aug, 2037
QLOSI 9867810 Aug, 2037
QVAR REDIHALER 11793953 Jan, 2038
RADICAVA ORS 11826352 Nov, 2039
RINVOQ 11780847 Oct, 2036
RINVOQ 11780848 Oct, 2036
RINVOQ 11787815 Oct, 2036
RINVOQ 11795175 Oct, 2036
TIBSOVO 11667673 Jan, 2033
TRALEMENT 11786548 Jul, 2041
TRELEGY ELLIPTA 7439393*PED Nov, 2025
TRELEGY ELLIPTA 8113199*PED Apr, 2028
TRELEGY ELLIPTA 8161968*PED Aug, 2028
TRELEGY ELLIPTA 8511304*PED Dec, 2027
TRELEGY ELLIPTA 8534281*PED Sep, 2030
TRELEGY ELLIPTA 8746242*PED Apr, 2031
TRELEGY ELLIPTA 9333310*PED Apr, 2028
TYVASO 11826327 Feb, 2042
TYVASO DPI 11826327 Feb, 2042
VELSIPITY 10301262 Jun, 2036
VELSIPITY 10676435 Jun, 2036
VELSIPITY 11007175 Jan, 2036
VELSIPITY 11091435 Jun, 2036
VELSIPITY 8580841 Mar, 2030
VELSIPITY 9126932 Jul, 2029
VELTASSA 10485821 Mar, 2024
VELTASSA 11123363 Oct, 2033
VELTASSA 7556799 Feb, 2025
VELTASSA 8147873 Jun, 2028
VELTASSA 8216560 Mar, 2027
VELTASSA 8282913 May, 2027
VELTASSA 8287847 Mar, 2024
VELTASSA 8337824 May, 2030
VELTASSA 8475780 Mar, 2024
VELTASSA 8778324 Mar, 2024
VELTASSA 8889115 Mar, 2024
VELTASSA 9492476 Oct, 2033
VELTASSA 9925212 Oct, 2033
VOQUEZNA 7977488 Aug, 2028
VOQUEZNA 9186411 Aug, 2030
XPHOZAH 10272079 Apr, 2034
XPHOZAH 10940146 Apr, 2034
XPHOZAH 8541448 Aug, 2033
XPHOZAH 8969377 Dec, 2029
XPOVIO 11787771 Jul, 2032
XPOVIO 11807629 Aug, 2035
XYOSTED (AUTOINJECTOR) 11813435 Feb, 2035
ZEGALOGUE 11795204 Jan, 2034
ZEGALOGUE (AUTOINJECTOR) 11795204 Jan, 2034
ZEPBOUND (AUTOINJECTOR) 11357820 Jun, 2039
ZEPBOUND (AUTOINJECTOR) 8734394 Feb, 2031
ZEPBOUND (AUTOINJECTOR) 9402957 Jun, 2031
ZEPBOUND (AUTOINJECTOR) 9474780 Jan, 2036
ZEPOSIA 11680050 Sep, 2038
ZILBRYSQ 10106579 Jun, 2035
ZILBRYSQ 10208089 Jun, 2035
ZILBRYSQ 10435438 Jun, 2035
ZILBRYSQ 10562934 Jun, 2035
ZILBRYSQ 10835574 Jun, 2035
ZILBRYSQ 11014965 Jun, 2035
ZILBRYSQ 11535650 Jun, 2035
ZILBRYSQ 11752190 Jun, 2035
ZORYVE 11819496 Jun, 2037
ZURZUVAE 10172871 Apr, 2034
ZURZUVAE 10342810 Apr, 2034
ZURZUVAE 11236121 Aug, 2037
ZURZUVAE 9512165 Apr, 2034
What's new on Pharsight!

Find the answers you need on Drugs.

Are you looking for accurate and reliable information on drugs and generics? Look no further! Our FAQ page is packed with answers to some of the most commonly asked questions about drugs. Visit and bookmark our FAQ page today!

Bonus - Don't see your question answered there? Contact us, and we'll be happy to help!

Check out FAQ page

Shoot first, and win big! Figure out the drugs that are about to enter the NCE-1 period to stay ahead of your generic launch strategy!

Want to be first-to-market with your generic drugs? Stay ahead of the game with our exclusive list of drugs facing patent challenges updated every month.

Check out NCE-1 period list

spacer_11

Our insights are consumed by 1000+ leading pharma companies

© 2023 GreyB Research